Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients

[1]  W. Anderson,et al.  Gene-marking to trace origin of relapse after autologous bone-marrow transplantation , 1993, The Lancet.

[2]  D. Valerio,et al.  Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  G. Johnson,et al.  Rhodamine123 reveals heterogeneity within murine Lin-, Sca-1+ hemopoietic stem cells , 1992, The Journal of experimental medicine.

[4]  J. Ihle,et al.  An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. , 1992, Blood.

[5]  J. Ihle,et al.  Retrovirus-mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation. , 1992, Human gene therapy.

[6]  R. M. Fox,et al.  Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy , 1992, The Lancet.

[7]  F. Appelbaum,et al.  Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogs. , 1991, Blood.

[8]  R. Marcus,et al.  Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. Graham-Pole,et al.  Myeloablative chemoradiotherapy and autologous bone marrow infusions for treatment of neuroblastoma: factors influencing engraftment. , 1991, Blood.

[10]  L. Fouillard,et al.  GM-CSF instead of autologous bone-marrow transplantation after the BEAM regimen , 1991, The Lancet.

[11]  J. R. Smith,et al.  Expression of a foreign gene in cats reconstituted with retroviral vector infected autologous bone marrow. , 1991, Blood.

[12]  A. Nienhuis,et al.  Survival and retrovirus infection of murine hematopoietic stem cells in vitro: effects of 5-FU and method of infection. , 1991, Experimental hematology.

[13]  K. Cornetta,et al.  Increased efficiency of retroviral-mediated gene transfer and expression in primate bone marrow progenitors after 5-fluorouracil- induced hematopoietic suppression and recovery , 1991 .

[14]  P. Lansdorp,et al.  Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. , 1991, Blood.

[15]  D. Linch,et al.  High-dose chemotherapy and autologous bone marrow transplantation in acute myeloid leukemia , 1990 .

[16]  A. Miller,et al.  Progress toward human gene therapy. , 1990, Blood.

[17]  W. Anderson,et al.  Retroviral vector-mediated transfer of the bacterial neomycin resistance gene into fetal and adult sheep and human hematopoietic progenitors in vitro. , 1990, Blood.

[18]  E. Niskanen,et al.  Progenitor cell numbers (CFU-GM, CFU-D, and CFU-Mix) and hemopoietic recovery following autologous marrow transplantation. , 1989, Experimental hematology.

[19]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[20]  A. Pileri,et al.  GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR TO HARVEST CIRCULATING HAEMOPOIETIC STEM CELLS FOR AUTOTRANSPLANTATION , 1989, The Lancet.

[21]  R. Gale,et al.  AUTOTRANSPLANTS IN LEUKAEMIA , 1989, The Lancet.

[22]  R. Bast,et al.  Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. , 1988, The New England journal of medicine.

[23]  M. Bender,et al.  Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region , 1987, Journal of virology.

[24]  J. Armitage,et al.  Autologous bone marrow transplants: Different indications in Europe and North America , 1989 .